VIBRANT HD

Pausiert

INFORMATIONEN

FÖRDERER

Novartis Pharmaceuticals

TEILNEHMER

75

Dies ist die erste Studie mit dem Medikament Branaplam bei Erwachsenen mit Huntington, in der die richtige Dosis ermittelt wird, die erforderlich ist, um die mHTT-Spiegel im Liquor so weit zu senken, dass sie über einen längeren Zeitraum wirksam sind.

Video introduction of Vibrant HD trial:

Alter für die Studie geeignet

25 Jahre bis 75 Jahre (Erwachsene, Ältere Erwachsene)

Geschlecht für die Studie geeignet

Alle

Nimmt gesunde Freiwillige auf

Nein

  • Vor der Teilnahme an der Studie muss eine unterzeichnete Einverständniserklärung vorliegen.
  • Klinisch diagnostizierte Huntington-Krankheit im Stadium 1 oder 2 mit einem diagnostischen Konfidenzniveau (DCL) = 4 und einer United Huntington’s Disease Rating Scale (UHDRS) Total Functional Capacity (TFC) >8 beim Screening.
  • Genetisch bestätigte Huntington-Krankheit mit Vorhandensein von ≥40 Cytosin-Adenin-Guanin (CAG)-Wiederholungen im Huntingtin-Gen.
  • Männliche und weibliche Teilnehmer, die am Tag der Unterzeichnung der Einverständniserklärung zwischen 25 und 75 Jahre alt sind.
  • Vorherige Teilnahme an einer klinischen Studie zur Untersuchung einer Huntingtin-senkenden Therapie (es sei denn, der Teilnehmer erhielt nur Placebo).
  • Teilnehmer, die Medikamente einnehmen, die nach dem Protokoll verboten sind.
    Jegliche medizinische Vorgeschichte,
  • Operationen an der Lendenwirbelsäule oder Zustände, die die Fähigkeit zur Durchführung der im Protokoll festgelegten Untersuchungen beeinträchtigen würden,
  • Teilnehmer mit anderen schweren, akuten oder chronischen Erkrankungen, einschließlich instabiler psychiatrischer Zustände, oder Laboranomalien, die nach Ansicht des Prüfers das mit der Studienteilnahme verbundene Risiko erhöhen oder die Interpretation der Studienergebnisse beeinträchtigen könnten.
  • Jeder chirurgische oder medizinische Zustand, der den Teilnehmer im Falle der Teilnahme an der Studie gefährden könnte.
  • Der Prüfarzt sollte diese Entscheidung unter Berücksichtigung der Krankengeschichte des Teilnehmers und/oder der klinischen oder Laborbefunde bei der Vorsorgeuntersuchung treffen.

LÄNDER

Frankreich

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Angers Cedex 1, France, 49033

 

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Creteil, France, 94010

 

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Lille Cedex, France, 59037

Ungarn

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Szeged, Hungary, 6725

 

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Szeged, Hungary, 6725

Deutschland

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Muenster, Germany, 48149

 

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Ulm, Germany, 89081

 

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Erlangen, Germany, 91054

Spanien

  • TRIAL SITE:
    Novartis Investigative Site
  • Address: Barcelona, Catalunya, Spain, 08036

 

  • TRIAL SITE: Novartis Investigative Site
  • Address: Barcelona, Spain, 08041

 

  • TRIAL SITE: Novartis Investigative Site
  • Address: Madrid, Spain, 28034
new FB feed (19)

dictionary:

SNP-single nucleotide polymorphisms

a single-letter spelling difference in a gene. SNPs, pronounced ‘snips’, are common and most don’t change the function of the gene.

 
new FB feed (19)

dictionary:

at risk

You do not know if you carry the genetic mutation for HD gene 

 
new FB feed (19)

dictionary:

TFC-total functional capacity

A standardized rating scale for function in HD, used to assess capacity to work, handle finances, perform domestic chores and self-care tasks.
Scores range from 0 to 13, with higher scores indicating better functional capacity. 

 
new FB feed (19)

dictionary:

Double-blinded

 means that neither the participant nor the clinical trial doctor can choose or know the group the participant is in until the trial is over. This approach helps to prevent bias.

new FB feed (19)

dictionary:

Open label

A trial in which the patient and doctor know what drug is being used. Open label trials are susceptible to bias through placebo effects.

new FB feed (19)

dictionary:

Gene therapy

a technique that aims to treat or prevent diseases by modifying a person’s genes. It involves introducing, removing, or changing genetic material (DNA or RNA) within a patient’s cells.

new FB feed (19)

dictionary:

UHDRS- Unified Huntington Disease Rating Scale

A standardized neurological examination that aims to provide a uniform assessment of the clinical features of HD

new FB feed (19)

dictionary:

CAG repeat

The stretch of DNA at the beginning of the HD gene, which contains the sequence CAG repeated many times, and is abnormally long in people who will develop HD

new FB feed (19)

dictionary:

Wild-type

the opposite of ‘mutant’. Wild-type huntingtin, for example, is the ‘normal’, ‘healthy’ protein

new FB feed (19)

dictionary:

Tolerabilty

How well a person can handle a treatment without having serious or uncomfortable side effects.

new FB feed (19)

dictionary:

Striatum

Part of the brain that  coordinates multiple aspects of cognition, including both motor and action planning, decision-making, motivation, reinforcement, and reward system.

new FB feed (19)

dictionary:

Randomized allocation

A type of allocation strategy in which participants are assigned to the arms of a clinical trial by chance.

new FB feed (19)

dictionary:

Radioligand

a radioactive substance that binds to a specific target in the body, allowing visualization of that target’s distribution and activity

new FB feed (19)

dictionary:

Protein

Protein builds, maintains, and replaces the tissues in your body. The building blocks of life.

new FB feed (19)

dictionary:

Premanifest / Prodromal

Prior to onset or diagnosis of movement symptoms.

new FB feed (19)

dictionary:

Placebo

A placebo is a dummy medicine containing no active ingredients. The placebo effect is a psychological effect that causes people to feel better even if they’re taking a pill that doesn’t work.

new FB feed (19)

dictionary:

PK - Pharmacokinetics

The movement of drugs through the body

new FB feed (19)

dictionary:

PD - Pharmacodynamics

The body’s biological response to drugs

new FB feed (19)

dictionary:

PET scan

Positron emission tomography which produces detailed 3-dimensional images of the inside of the body.

new FB feed (19)

dictionary:

Neuron

Brain cells that store and transmit information

new FB feed (19)

dictionary:

MRI

Magentic resonance imaging: A technique using powerful magnetic fields to produce detailed images and visualizes the structure of organs, tissues, and bones 

new FB feed (19)

dictionary:

mHTT

Mutant huntingtin protein. The protein produced by the faulty HD gene.

new FB feed (19)

dictionary:

Manifest

after HD diagnosis, or when symptoms are already showing

new FB feed (19)

dictionary:

Longitudinal study

A study where each participant is looked at several times over a time period – unlike a cross-sectional study, where each participant is looked at only once

new FB feed (19)

dictionary:

HTT

one abbreviation for the gene that causes Huntington’s disease. The same gene is also called HD and IT-15

new FB feed (19)

dictionary:

fMRI

functional MRI:As with MRI, a technique using powerful magnetic fields  but focusing on brain function by measuring and mapping changes in blood flow, revealing which areas of the brain are active during specific tasks or cognitive processes

new FB feed (19)

dictionary:

CSF - cerebrospinal fluid

A clear fluid produced by the brain, which surrounds and supports the brain and spinal cord.

new FB feed (19)

dictionary:

Efficacy

A measure of whether a treatment works or not

new FB feed (19)

dictionary:

ASO(Antisense oligonucleotides)

A type of gene silencing treatment in which specially designed DNA molecules are used to switch off a gene

new FB feed (19)

dictionary:

Biomarker

a test of any kind – including blood tests, thinking tests and brain scans – that can measure or predict the progression of a disease like HD. Biomarkers may make clinical trials of new drugs quicker and more reliable

new FB feed (19)

dictionary:

BDNF

Brain-derived neurotrophic factor: a growth factor that may be able to protect neurons in HD.

new FB feed (19)

dictionary:

Allele

one of the two copies of a gene

new FB feed (19)

dictionary:

Plasma

Liquid component of the blood.

new FB feed (19)

dictionary:

Gene

The basic unit of heredity passed from parent to child. Genes are made up of sequences of DNA and are arranged, one after another, at specific locations on chromosomes in the nucleus of cells.

new FB feed (19)

dictionary:

Phase

Clinical trial phases are different stages of research that assess the safety and effectiveness of a new medical treatment or intervention in humans.

Each phase has a specific goal and involves a different number of participants. Generally, there are 4 phases (I-IV), with Phase I focusing on safety and dosage, Phase II on efficacy and side effects, Phase III on comparing the new treatment with standard treatments, and Phase IV on long-term safety monitoring.